Cme program exam and answer sheet
No abstract available (Source: Obstetrical and Gynecological Survey)
Source: Obstetrical and Gynecological Survey - January 1, 2020 Category: OBGYN Tags: CME PROGRAM EXAM AND ANSWER SHEET Source Type: research

Induction of Labor: An Overview of Guidelines
Conclusions The World Health Organization seems to be the most evidence-based guideline with recommendations based mainly on Cochrane reviews. The variation in the clinical indications and methods of IOL highlights the need to adopt an international consensus, which may help to optimize the quality of obstetric care and further promote evidence-based medicine. Target Audience Obstetricians and gynecologists, family physicians. Learning Objectives After participating in this activity, the learner should be better able to identify the appropriate indications for induction of labor; explain the effectiveness and assoc...
Source: Obstetrical and Gynecological Survey - January 1, 2020 Category: OBGYN Tags: CME ARTICLES Source Type: research

Management Considerations for Recalcitrant Hyperemesis
Conclusions and Relevance Hyperemesis gravidarum is a diagnosis reserved for refractory cases of NVP and therefore by definition poses treatment challenges. Any clinical presentation that lent itself to prescriptive, algorithmic management would likely fall short of the diagnostic criteria for HEG. However, data can inform management on a patient-by-patient basis or at least help patient and provider understand risks and benefits of therapies reserved for refractory cases. Target Audience Obstetricians and gynecologists, family physicians. Learning Objectives After completing this activity, the learner should be be...
Source: Obstetrical and Gynecological Survey - January 1, 2020 Category: OBGYN Tags: CME ARTICLES Source Type: research

Collateral Damage: Maternal Obesity During Pregnancy Continues to Rise
Conclusions and Relevance Are current prepregnancy lifestyle and behavioral interventions feasible to prevent maternal obesity complications? Epigenetic and metabolomic research will be critical to determine what is needed to blunt the effects of maternal obesity and to discover successful treatment. Target Audience Obstetricians, gynecologists, family physicians, midwives, nurse practitioners, and dietitians Learning Objectives After participating in this activity, the learner should be better able to identify lifestyle interventions used to prevent complications from an obese pregnancy; describe emerging maternal...
Source: Obstetrical and Gynecological Survey - January 1, 2020 Category: OBGYN Tags: CME ARTICLES Source Type: research

What Is the Clinical Impact of the Endometrial Receptivity Array in PGT-A and Oocyte Donation Cycles?
(Abstracted from J Assist Reprod Genet 2019;36:1901–1908) Endometrial receptivity is a critical factor to likelihood of implantation after embryonic transfer (ET), yet potential biomarkers for receptivity have thus far failed at reliably predicting clinical pregnancy. Recent evidence has suggested that the Endometrial Receptivity Analysis (ERA), a microarray-based test to evaluate endometrial gene expression, may be valuable in prediction of endometrial receptivity and recommendation of endometrial preparation before ET. (Source: Obstetrical and Gynecological Survey)
Source: Obstetrical and Gynecological Survey - January 1, 2020 Category: OBGYN Tags: GYNECOLOGY: INFERTILITY/REPRODUCTIVE TECHNOLOGIES Source Type: research

Endometriosis and Cumulative Live Birth Rate After Fresh and Frozen IVF Cycles With Single Embryo Transfer in Young Women: No Impact Beyond Reduced Ovarian Sensitivity—A Case Control Study
(Abstracted from J Assist Reprod Genet 2019;36:1649–1656) Although endometriosis affects approximately 10% of women of reproductive age and 40% of infertile women, the physiological mechanism of how this chronic inflammatory disease affects fertility remains unclear. There is little consensus in the literature that IVF/ICSI outcomes are impacted by endometriosis. (Source: Obstetrical and Gynecological Survey)
Source: Obstetrical and Gynecological Survey - January 1, 2020 Category: OBGYN Tags: GYNECOLOGY: INFERTILITY/REPRODUCTIVE TECHNOLOGIES Source Type: research

Family Planning Training at Catholic and Other Religious Hospitals: A National Survey
(Abstracted from Am J Obstet Gynecol 2019; DOI: 10.1016/j.ajog.2019.09.012) The Accreditation Council for Graduate and Medical Education (ACGME) has recognized family planning and abortion training as essential components of all obstetrics and gynecology residency programs, regardless of institutional affiliation, and has stipulated that such training be a comprehensive part of their planned curriculum (“routine training”). It has also been recognized by ACGME that residents who have religious or moral objections to abortion training may decline (“opt-out”) of training. (Source: Obstetrical and Gynecological Survey)
Source: Obstetrical and Gynecological Survey - January 1, 2020 Category: OBGYN Tags: GYNECOLOGY: ETHICS, MEDICOLEGAL ISSUES, AND PUBLIC POLICY Source Type: research

Quality of Care and Outcomes of Patients With Gynecologic Malignancies Treated at Safety-Net Hospitals
(Abstracted from JNCI Cancer Spectr 2019;3(3):pkz039) There are well-documented impacts of socioeconomic factors such as race and insurance status on outcomes for women with gynecologic malignancies; however, the role of hospital characteristics in modulating outcomes is less understood. Safety-net hospitals (SNHs), defined by the relative number of uninsured or Medicaid patients, play a critical role by serving the most vulnerable patients and improving access to care for many Americans. (Source: Obstetrical and Gynecological Survey)
Source: Obstetrical and Gynecological Survey - January 1, 2020 Category: OBGYN Tags: GYNECOLOGY: GYNECOLOGIC ONCOLOGY Source Type: research

Niraparib in Patients With Newly Diagnosed Advanced Ovarian Cancer
(Abstracted from N Engl J Med 2019;381:2391–2402) The standard treatment for newly diagnosed advanced epithelial ovarian cancer involves cytoreductive surgery and platinum-taxane combination chemotherapy. Unfortunately, recurrence occurs in up to 85% of patients after completing this chemotherapy regimen. (Source: Obstetrical and Gynecological Survey)
Source: Obstetrical and Gynecological Survey - January 1, 2020 Category: OBGYN Tags: GYNECOLOGY: GYNECOLOGIC ONCOLOGY Source Type: research

Vaginal Bromocriptine Improves Pain, Menstrual Bleeding, and Quality of Life in Women With Adenomyosis: A Pilot Study
(Abstracted from Acta Obstet Gynecol Scand 2019;98:1341–1350) Animal models suggest that increased uterine prolactin concentration is a risk factor for adenomyosis. Prolactin is produced in the human endometrium, myometrium, and the pituitary gland and acts as a smooth muscle cell mitogen in vitro. (Source: Obstetrical and Gynecological Survey)
Source: Obstetrical and Gynecological Survey - January 1, 2020 Category: OBGYN Tags: GYNECOLOGY: OFFICE GYNECOLOGY Source Type: research

Effect of Behavioral and Pelvic Floor Muscle Therapy Combined With Surgery Versus Surgery Alone on Incontinence Symptoms Among Women With Mixed Urinary Incontinence: The ESTEEM Randomized Clinical Trial
(Abstracted from JAMA 2019;322:1066–1076) It is estimated that urinary incontinence (UI) affects up to 58% of women and has a significant negative impact on their quality of life. Mixed UI includes both stress and urgency incontinence and is present in up to half of women with UI. (Source: Obstetrical and Gynecological Survey)
Source: Obstetrical and Gynecological Survey - January 1, 2020 Category: OBGYN Tags: GYNECOLOGY: UROGYNECOLOGY Source Type: research

Effect of Vaginal Mesh Hysteropexy Versus Vaginal Hysterectomy With Uterosacral Ligament Suspension on Treatment Failure in Women With Uterovaginal Prolapse: A Randomized Clinical Trial
(Abstracted from JAMA 2019;322:1054–1065) Two surgical options for patients with uterovaginal prolapse are vaginal hysterectomy with suture apical suspension or transvaginal mesh hysteropexy, a uterine preservation procedure. An analysis of a US database from 2007 to 2011 estimated that 13% of women underwent pelvic organ prolapse surgery by the age of 80 years. (Source: Obstetrical and Gynecological Survey)
Source: Obstetrical and Gynecological Survey - January 1, 2020 Category: OBGYN Tags: GYNECOLOGY: UROGYNECOLOGY Source Type: research

Effects of Shared Decision Making on Opioid Prescribing After Hysterectomy
(Abstracted from Obstet Gynecol 2019;134:823–833) Opioid use disorder is an epidemic. In the United States, more than 11 million people abused prescription opioids in 2016. (Source: Obstetrical and Gynecological Survey)
Source: Obstetrical and Gynecological Survey - January 1, 2020 Category: OBGYN Tags: GYNECOLOGY: OPERATIVE GYNECOLOGY Source Type: research

A CRISPR Focus on Attitudes and Beliefs Toward Somatic Genome Editing From Stakeholders Within the Sickle Cell Disease Community
(Abstracted from Genetics Med 2019;21:1726–1734. (Source: Obstetrical and Gynecological Survey)
Source: Obstetrical and Gynecological Survey - January 1, 2020 Category: OBGYN Tags: OBSTETRICS: GENETICS Source Type: research

Maternal and Neonatal Outcomes Associated With Trophectoderm Biopsy
(Abstracted from Fertil Steril 2019;112:283–290.e2) The use of preimplantation genetic testing (PGT) is increasing rapidly, having gone from 4% of all cycles in 2005 to over 22% in 2015. Despite this increasing use, maternal and neonatal outcomes for pregnancies achieved via in vitro fertilization (IVF) with PGT have very little assessment. (Source: Obstetrical and Gynecological Survey)
Source: Obstetrical and Gynecological Survey - January 1, 2020 Category: OBGYN Tags: OBSTETRICS: OBSTETRICAL COMPLICATIONS Source Type: research

Neonatal Developmental and Behavioral Outcomes of Immediate Delivery Versus Expectant Monitoring in Mild Hypertensive Disorders of Pregnancy: 2-Year Outcomes of the HYPITAT-II Trial
(Abstracted from Am J Obstet Gynecol 2019;221:154.e1–154.e11) Hypertensive pregnancy disorders complicate up to 10% of pregnancies worldwide, resulting in significant maternal and neonatal morbidity. The only definitive treatment for hypertensive disorders is delivery. (Source: Obstetrical and Gynecological Survey)
Source: Obstetrical and Gynecological Survey - January 1, 2020 Category: OBGYN Tags: OBSTETRICS: NEONATAL COMPLICATIONS Source Type: research

Association of Thyroid Function Test Abnormalities and Thyroid Autoimmunity With Preterm Birth: A Systematic Review and Meta-analysis
(Abstracted from JAMA 2019;322(7):632–641) Preterm birth complicates 5% to 15% of births worldwide, and although it is the most important direct cause of morbidity and mortality in children younger than 5 years, no known risk factors can be identified in the majority of cases. However, overt hypothyroidism and hyperthyroidism during pregnancy are well-known risk factors for preterm birth, and as such, the purpose of this study was to assess whether thyroid function test abnormalities and thyroid peroxidase (TPO) antibody positivity were associated with preterm birth. (Source: Obstetrical and Gynecological Survey)
Source: Obstetrical and Gynecological Survey - January 1, 2020 Category: OBGYN Tags: OBSTETRICS: MEDICAL COMPLICATIONS OF PREGNANCY Source Type: research

Abortion Rights in Peril—What Clinicians Need to Know
(Abstracted from N Engl J Med 2019;381(6):497–449) Although attempts to ban abortion in the United States have been common since the 1973 Roe vs Wade and Doe vs Bolton decisions, 2019 has seen an unprecedented surge of abortion restrictions passed by states. The past 46 years have seen more than 1200 laws restricting abortion access put in place, despite continuous rulings by the Supreme Court affirming the constitutional right to abortion. (Source: Obstetrical and Gynecological Survey)
Source: Obstetrical and Gynecological Survey - January 1, 2020 Category: OBGYN Tags: OBSTETRICS: ETHICS, MEDICOLEGAL ISSUES, AND PUBLIC POLICY Source Type: research

Hearing Loss With Congenital Cytomegalovirus Infection
(Abstracted from Pediatrics 2019;144(2):e20183095) Congenital cytomegalovirus (cCMV) infection is the most common fetal viral infection and is the leading cause of nonhereditary sensorineural hearing loss (SNHL) in the developed world. This prospective study aimed to determine the incidence of SNHL in 157 children with proven cCMV infection, along with searching for risk determinants for developing hearing loss and proposing recommendations for screening and follow-up with the newborn. (Source: Obstetrical and Gynecological Survey)
Source: Obstetrical and Gynecological Survey - January 1, 2020 Category: OBGYN Tags: OBSTETRICS: NEWBORN MEDICINE Source Type: research

Is Traditional Perinatal Autopsy Needed After Detailed Fetal Ultrasound and Postmortem MRI?
(Abstracted from Prenat Diagn 2019;39:818–829) Investigation after birth of fetal anomalies detected on prenatal ultrasound (US) is important, particularly after termination of pregnancy or fetal or perinatal loss, in terms of significant implications for genetic counseling, subsequent reproductive choices, and other family members. Confirmation of perinatal findings can traditionally be confirmed at a perinatal autopsy, but only 40% of parents consent to this procedure. (Source: Obstetrical and Gynecological Survey)
Source: Obstetrical and Gynecological Survey - January 1, 2020 Category: OBGYN Tags: OBSTETRICS: FETAL DIAGNOSIS AND THERAPY Source Type: research

Can Ultrasound in Early Gestation Improve Visualization of Fetal Cardiac Structures in Obese Pregnant Women?
(Abstracted from J Ultrasound Med 2019;38:2057–2063) The worldwide obesity epidemic has led to more than 1.9 billion adults 18 years of age or older classified as “obese.” As obesity is associated with greater risk of maternal and feto-neonatal complications, this study aimed to assess the utility of early gestational ultrasounds (USs) in cardiac screening for obese patients. This entailed performing both late first-trimester/early second-trimester transvaginal and transabdominal US, in comparison with the current national guideline-based second-trimester abdominal US for initial fetal cardiac screening ...
Source: Obstetrical and Gynecological Survey - January 1, 2020 Category: OBGYN Tags: OBSTETRICS: FETAL DIAGNOSIS AND THERAPY Source Type: research

Cme program exam and answer sheet
No abstract available (Source: Obstetrical and Gynecological Survey)
Source: Obstetrical and Gynecological Survey - December 1, 2019 Category: OBGYN Tags: CME PROGRAM EXAM AND ANSWER SHEET Source Type: research

The Morcellation “Debate” and the FDA 510(k) Process—A Call for Further Reform
Conclusions The current system currently transfers the responsibility of ensuring safety and efficacy to the public, patients, and providers. To minimize potential harm, the FDA needs to incorporate a greater standard of evidence into its framework for the approval and regulation of medical devices. The burden of these requirements should be borne at least in part by the companies bringing equipment to market. Relevance It is incumbent on all surgeons to be vigilant in their objective critical assessment of new instrumentation and report their outcomes after they come to market. Target Audience Obstetricians and gy...
Source: Obstetrical and Gynecological Survey - December 1, 2019 Category: OBGYN Tags: CME ARTICLES Source Type: research

Associations Between Migraine and Adverse Pregnancy Outcomes: Systematic Review and Meta-analysis
Conclusions A history of migraine is significantly associated with an increased risk of adverse pregnancy outcomes including PE and LBW. We hypothesize that shared pathophysiology due to underlying preclinical cardiovascular risk in women with migraine might play a role during pregnancy. Relevance Pregnant women with a history of migraine should be considered at higher risk of adverse pregnancy outcomes and should be informed, monitored, and treated preventively accordingly. Target Audience Obstetricians and gynecologists, family physicians. Learning Objectives After completing this activity, the learner should ...
Source: Obstetrical and Gynecological Survey - December 1, 2019 Category: OBGYN Tags: CME ARTICLES Source Type: research

Preimplantation Genetic Testing for Aneuploidy: A Review
Conclusions At times during its infancy, PGT-A failed to display conclusive improvements in results; with newer technologies, PGT-A appears to yield superior outcomes, including reductions in miscarriages and multiple gestations. Clinicians and patients should assess the use of PGT-A on a case-by-case basis, with laboratories encouraged to utilize blastocyst biopsy and next-generation sequencing when conducting PGT-A. Further studies providing cumulative live birth rates and time to live birth are required if PGT-A is to be proven as producing superior outcomes. Relevance PGT-A has the potential ability to impact in v...
Source: Obstetrical and Gynecological Survey - December 1, 2019 Category: OBGYN Tags: CME ARTICLES Source Type: research

Modified Natural-Cycle Cryopreserved Embryo Transfer: Is a Washout Period Needed After a Failed Fresh Cycle?
(Abstracted from Reprod Biomed Online 2019;39(3):439–445) Embryo cryopreservation and frozen embryo transfer (FET) in assisted reproductive technology currently accounts for up to one third of all children born in the United States using assisted reproductive technology. Embryo cryopreservation's increase in utilization is driven by advances in procedures associated with the technology as well as increased understanding of downstream effects associated with ovarian stimulation. (Source: Obstetrical and Gynecological Survey)
Source: Obstetrical and Gynecological Survey - December 1, 2019 Category: OBGYN Tags: GYNECOLOGY: INFERTILITY/REPRODUCTIVE TECHNOLOGIES Source Type: research

Trial of SAGE-217 in Patients With Major Depressive Disorder
(Abstracted from N Engl J Med 2019;381(10):903–911) Positive allosteric modification of GABAA receptors via SAGE-217, an oral synthetic neurosteroid, has been proposed as a treatment for major depressive disorder. (Source: Obstetrical and Gynecological Survey)
Source: Obstetrical and Gynecological Survey - December 1, 2019 Category: OBGYN Tags: GYNECOLOGY: ENDOCRINOLOGY OF PREGNANCY Source Type: research

Access to Contraception in Local Health Departments, Four Midwest States, 2017–2018
(Abstracted from Contraception 2019;99:363–367) Barriers to contraception use are well known and include education, cost, and access. Successful efforts to expand access for women of reproductive age to a broad range of contraceptive methods focus on intrauterine devices (IUDs) and implants, which are long-acting reversible methods. (Source: Obstetrical and Gynecological Survey)
Source: Obstetrical and Gynecological Survey - December 1, 2019 Category: OBGYN Tags: GYNECOLOGY: ETHICS, MEDICOLEGAL ISSUES, AND PUBLIC POLICY Source Type: research

Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-related Cancer: US Preventive Services Task Force Recommendation Statement
(Abstracted from JAMA 2019;322(7):652–665) For women in the United States, BRCA1/2 mutations occur in approximately 1 in 300 to 500 women. Risk of ovarian, fallopian, and peritoneal cancer is also increased to 39% in those with BRCA1 mutations and 10% to 17% for those with BRCA2 mutations. (Source: Obstetrical and Gynecological Survey)
Source: Obstetrical and Gynecological Survey - December 1, 2019 Category: OBGYN Tags: GYNECOLOGY: GYNECOLOGIC ONCOLOGY Source Type: research

Patient Preferences for Attributes of Primary Surgical Debulking Versus Neoadjuvant Chemotherapy for Treatment of Newly Diagnosed Ovarian Cancer
(Abstracted from Cancer 2019;125:4399–4406) Retrospective analyses have found that optimal tumor debulking after a new diagnosis of ovarian cancer results in significantly greater progression-free survival (PFS) and overall survival (OS) compared with those who are suboptimally debulked. Primary debulking surgery (PDS) has become a common first line of therapy in patients with ovarian cancer. (Source: Obstetrical and Gynecological Survey)
Source: Obstetrical and Gynecological Survey - December 1, 2019 Category: OBGYN Tags: GYNECOLOGY: GYNECOLOGIC ONCOLOGY Source Type: research

Two-Dose Versus Single-Dose Methotrexate for Treatment of Ectopic Pregnancy: A Meta-analysis
(Abstracted from Am J Obstet Gynecol 2019;221:95–108.e2) A number of studies have demonstrated comparable efficacy of medical and surgical management for treatment of stable ectopic pregnancies. Methotrexate, a folate antagonist, has been the mainstay of medical management. (Source: Obstetrical and Gynecological Survey)
Source: Obstetrical and Gynecological Survey - December 1, 2019 Category: OBGYN Tags: GYNECOLOGY: OFFICE GYNECOLOGY Source Type: research

Sexual Satisfaction Changes Reported by Men After Their Partners' Robotic-assisted Laparoscopic Sacrocolpopexies
(Abstracted from Female Pelvic Med Reconstr Surg 2019;25:365–368) Most women with symptomatic pelvic organ prolapse (POP) experience improved sexual function after successful POP repair. Little is known about the impact of their reconstructive surgery on their male partners' sexual function and satisfaction. (Source: Obstetrical and Gynecological Survey)
Source: Obstetrical and Gynecological Survey - December 1, 2019 Category: OBGYN Tags: GYNECOLOGY: UROGYNECOLOGY Source Type: research

Transvaginal Trigger Point Injections Improve Pain Scores in Women With Pelvic Floor Hypertonicity and Pelvic Pain Conditions
(Abstracted from Female Pelvic Med Reconstr Surg 2019;25:392–396) About 1 in 7 women in the United States has chronic pelvic pain. This condition has a negative impact on quality of life as a result of significant physical, emotional, and psychological effects. (Source: Obstetrical and Gynecological Survey)
Source: Obstetrical and Gynecological Survey - December 1, 2019 Category: OBGYN Tags: GYNECOLOGY: UROGYNECOLOGY Source Type: research

Ulipristal Acetate vs Gonadotropin-Releasing Hormone Agonists Prior to Laparoscopic Myomectomy (MYOMEX Trial): Short-term Results of a Double-blind Randomized Controlled Trial
(Abstracted from Acta Obstet Gynecol Scand 2019; doi: 10.1111/aogs.13713) Two agents used for pretreatment of fibroids before myomectomy are gonadotropin-releasing hormone agonists (GnRHa)—considered a criterion standard—and ulipristal acetate (UPA), a selective progesterone receptor modulator (SPRM) recently approved for preoperative treatment. No randomized trials have compared pretreatment of uterine fibroids with GnRHa or UPA prior to laparoscopic myomectomy. (Source: Obstetrical and Gynecological Survey)
Source: Obstetrical and Gynecological Survey - December 1, 2019 Category: OBGYN Tags: GYNECOLOGY: OPERATIVE GYNECOLOGY Source Type: research

Maternal Anemia and Pregnancy Outcomes: A Population-based Study
(Abstracted from J Perinatol 2019;39(7):911–919) Anemia is a common disorder that affects about 40% of pregnancies worldwide and has been associated with adverse events in both the mother and infant. An increased risk of cesarean delivery, red blood cell transfusion, and death has been documented in anemic pregnant women. (Source: Obstetrical and Gynecological Survey)
Source: Obstetrical and Gynecological Survey - December 1, 2019 Category: OBGYN Tags: OBSTETRICS: MEDICAL COMPLICATIONS OF PREGNANCY Source Type: research

Gestational Diabetes and the Risk of Late Stillbirth: A Case-Control Study From England, UK
(Abstracted from BJOG 2019;126:973–982) A high prevalence of late-term stillbirths in the United Kingdom has prompted a study to investigate whether a relationship exists between gestational diabetes mellitus (GDM) and stillbirth. Preexisting diabetes is associated with a significant increase of 4- to 6-fold in risk of stillbirth, but the relationship between GDM and stillbirth risk is indeterminate. (Source: Obstetrical and Gynecological Survey)
Source: Obstetrical and Gynecological Survey - December 1, 2019 Category: OBGYN Tags: OBSTETRICS: MEDICAL COMPLICATIONS OF PREGNANCY Source Type: research

State Abortion Restrictions and the New Supreme Court: Women's Access to Reproductive Health Services
(Abstracted from JAMA 2019;322(1):21–22) The US Supreme Court's landmark 1973 ruling in Roe v Wade established a privacy right to choose abortion. However, in more recent years, many judicial cases have emerged as blatant challenges to this ruling. (Source: Obstetrical and Gynecological Survey)
Source: Obstetrical and Gynecological Survey - December 1, 2019 Category: OBGYN Tags: OBSTETRICS: ETHICS, MEDICOLEGAL ISSUES, AND PUBLIC POLICY Source Type: research

Screening for Hepatitis B Virus Infection in Pregnant Women: US Preventive Services Task Force Reaffirmation Recommendation Statement
(Abstracted from JAMA 2019;322(4):349–354) In 2009, the US Preventive Services Task Force (USPSTF) recommended that pregnant women be screened for hepatitis B virus (HBV) infection. It cited strong evidence that the benefit of screening substantially outweighed the harm. (Source: Obstetrical and Gynecological Survey)
Source: Obstetrical and Gynecological Survey - December 1, 2019 Category: OBGYN Tags: OBSTETRICS: NEWBORN MEDICINE Source Type: research

Neurologic Outcome After Prematurity: Perspectives of Parents and Clinicians
(Abstracted from Pediatrics 2019;144(1):e20183819) Clinicians and parents often need to make time-sensitive and high-stakes decisions when caring for premature infants. Yet, little is known about how each group discusses, understands, and makes these decisions. (Source: Obstetrical and Gynecological Survey)
Source: Obstetrical and Gynecological Survey - December 1, 2019 Category: OBGYN Tags: OBSTETRICS: NEWBORN MEDICINE Source Type: research

Labor Induction in Late-Onset Fetal Growth Restriction: Foley Balloon Versus Vaginal Dinoprostone
(Abstracted from Fetal Diagn Ther 2019;46(1):67–74) Fetal growth restriction (FGR) is associated with a higher risk of perinatal complications and death, as well as neurodevelopmental delay. Once FGR is diagnosed, delivery is the main therapeutic measure. (Source: Obstetrical and Gynecological Survey)
Source: Obstetrical and Gynecological Survey - December 1, 2019 Category: OBGYN Tags: OBSTETRICS: MANAGEMENT OF LABOR, DELIVERY, AND THE PUERPERIUM Source Type: research

Sonographic Lower Uterine Segment Thickness After Prior Cesarean Section to Predict Uterine Rupture: A Systematic Review and Meta-analysis
(Abstracted from Acta Obstet Gynecol Scand 2019;98:830–841) Cesarean delivery rates in the United States were 32% in 2015. This high rate is coupled with dramatically decreased rates of trial of labor after cesareans (TOLACs) in recent years that may indicate fear of potential complications (such as uterine rupture). (Source: Obstetrical and Gynecological Survey)
Source: Obstetrical and Gynecological Survey - December 1, 2019 Category: OBGYN Tags: OBSTETRICS: MANAGEMENT OF LABOR, DELIVERY, AND THE PUERPERIUM Source Type: research

Cme program exam and answer sheet
No abstract available (Source: Obstetrical and Gynecological Survey)
Source: Obstetrical and Gynecological Survey - November 1, 2019 Category: OBGYN Tags: CME PROGRAM EXAM AND ANSWER SHEET Source Type: research

Physical Activity: Impact on Survival in Gynecologic Cancer
Conclusions and Relevance Health care providers caring for women with gynecologic malignancies must counsel patients regarding the importance of physical activity. This should include a discussion of the health benefits and, specifically, the cancer-related benefits. A personalized approach to physical activity intervention is essential. Target Audience Obstetricians and gynecologists, family physicians. Learning Objectives After completing this activity, the learner should be better able to summarize the physical activity recommendations for adults; describe health benefits of physical activity and review the hypo...
Source: Obstetrical and Gynecological Survey - November 1, 2019 Category: OBGYN Tags: CME ARTICLES Source Type: research

Bell’s Palsy in Pregnancy
Conclusions and Relevance To date, there is limited literature in the diagnosis and treatment of Bell's palsy during pregnancy. The prognosis of Bell's palsy in pregnancy is worse than in nonpregnant individuals. Early treatment with steroids is recommended, but not without risk. Target Audience Obstetricians and gynecologists, family physician. Learning Objectives After completing this activity, the learner should be better able to identify clinical features and presentations of Bell's palsy; differentiate between the treatment and prognosis of Bell's palsy during pregnancy versus nonpregnancy; and assess the risk...
Source: Obstetrical and Gynecological Survey - November 1, 2019 Category: OBGYN Tags: CME ARTICLES Source Type: research

Cardiometabolic Risk Factors and Benign Gynecologic Disorders
Conclusion and Relevance Clinical implications of these associations are 2-fold. First, screening and early modification of CMRFs can be part of a preventive strategy for uterine leiomyomas and hysterectomy. Second, patients diagnosed with uterine leiomyomas or endometriosis can be screened and closely followed for CMRFs and cardiovascular disease. Target Audience Obstetricians and gynecologists, family physicians. Learning Objectives After participating in this activity, the learner should be better able to identify the association between cardiometabolic risk factors and benign gynecologic disorders; explain the ...
Source: Obstetrical and Gynecological Survey - November 1, 2019 Category: OBGYN Tags: CME ARTICLES Source Type: research

Implementing Best Practices for the Provision of Long-acting Reversible Contraception: A Survey of Obstetrician-Gynecologists
(Abstracted from Contraception 2019;100:123–127) The most effective long-acting reversible contraceptives (LARCs) are intrauterine devices (IUDs) and contraceptive implants. Although LARCs are safe for nulliparous women and adolescents in the immediate postpartum and postabortion periods, the proportion of reproductive-aged women using contraceptives is low. (Source: Obstetrical and Gynecological Survey)
Source: Obstetrical and Gynecological Survey - November 1, 2019 Category: OBGYN Tags: GYNECOLOGY: OPERATIVE GYNECOLOGY Source Type: research

Maternal and Neonatal Outcomes Associated With Trophectoderm Biopsy
(Abstracted from Fertil Steril 2019;112:283–290) Despite a widespread increase in the use of preimplantation genetic testing (PGT), there remains inconclusive examination of maternal and neonatal outcomes after pregnancy achieved through in vitro fertilization (IVF) with PGT. It has been proposed that abnormal placentation may occur at a higher rate in pregnancies after PGT due to the removal of trophectoderm cells during biopsy, leading to higher rates of preeclampsia and restricted fetal growth. (Source: Obstetrical and Gynecological Survey)
Source: Obstetrical and Gynecological Survey - November 1, 2019 Category: OBGYN Tags: GYNECOLOGY: INFERTILITY/REPRODUCTIVE TECHNOLOGIES Source Type: research

Neonatal Outcomes of Live Births After Blastocyst Biopsy in Preimplantation Genetic Testing Cycles: A Follow-up of 1721 Children
(Abstracted from Fertil Steril 2019;112:82–88) Blastocyst biopsy as a means of preimplantation genetic testing (PGT) continues to increase in popularity and might provide a greater number of viable cells per biopsy compared with cleavage-stage biopsy. The increased number of testable cells enables the application of comprehensive chromosome screening modalities including next-generation sequencing, as well as the combination of multiple genetic tests. (Source: Obstetrical and Gynecological Survey)
Source: Obstetrical and Gynecological Survey - November 1, 2019 Category: OBGYN Tags: GYNECOLOGY: INFERTILITY/REPRODUCTIVE TECHNOLOGIES Source Type: research

Use and Misuse of Opioids After Gynecologic Surgical Procedures
(Abstracted from Obstet Gynecol 2019;134(2):250–260) The majority of opioid use disorders originate legally through prescriptions to the individual or through diverted medications; however, for various reasons, use often switches to use of cheaper illicit substances such as heroin. Recent literature has shown that 22% of opioids prescribed to opioid-naive patients are due to surgical procedures, with 1 study finding that of 36,000 patients who underwent surgery, 6% of patients prescribed a perioperative opioid developed persistent use more than 90 days postoperatively. (Source: Obstetrical and Gynecological Survey)
Source: Obstetrical and Gynecological Survey - November 1, 2019 Category: OBGYN Tags: GYNECOLOGY: GYNECOLOGIC ONCOLOGY Source Type: research

Universal Endometrial Cancer Tumor Typing: How Much Has Immunohistochemistry, Microsatellite Instability, and: MLH1: Methylation Improved the Diagnosis of Lynch Syndrome Across the Population?
(Abstracted from Cancer 2019;125(18):3172–3183) Lynch syndrome caused by germline mutations in several DNA mismatch repair (MMR) proteins is the most common cause of hereditary and endometrial cancers. Lynch syndrome accounts for approximately 2% to 3% of all endometrial cancers, although the lifetime risk of endometrial cancer for patients with Lynch syndrome varies depending on the specific mutation. (Source: Obstetrical and Gynecological Survey)
Source: Obstetrical and Gynecological Survey - November 1, 2019 Category: OBGYN Tags: GYNECOLOGY: GYNECOLOGIC ONCOLOGY Source Type: research